Pharmacology, Toxicology and Pharmaceutical Science
Escherichia coli
100%
Human
71%
Animal
71%
Quinolone Derivative
57%
Extended Spectrum Beta Lactamase
42%
Virulence
42%
Antimicrobial Resistance
28%
Antibiotics
28%
Pathogenicity Island
28%
Ciprofloxacin
14%
Prevalence
14%
Antiinfective Agent
14%
Nalidixic Acid
14%
Quinolone
14%
Chicken
14%
Absence
14%
Immunology and Microbiology
Escherichia coli
100%
Animal
85%
Human
71%
Virulence
42%
Spectrum
42%
Antimicrobial Resistance
28%
Pathogenicity Island
28%
Chicken
14%
Prevalence
14%
Development
14%
Sample
14%
Introspection
14%
Medicine and Dentistry
Escherichia coli
100%
Quinolone Derivative
57%
Extended Spectrum Beta Lactamase
42%
Virulence
42%
Polymerase Chain Reaction
42%
Antibiotic Resistance
28%
Prevalence
14%
Antiinfective Agent
14%
Quinolone
14%
Ciprofloxacin
14%
Development
14%
Absence
14%
Nalidixic Acid
14%
Introspection
14%
Gut
14%
Veterinary Science and Veterinary Medicine
Antibiotic Resistance
28%
Escherichia coli
14%
Food Animal Veterinary Medicine
14%
Food Science
Food Supply
14%
Food Product
14%